Hepatitis
New hepatitis research from Gentofte University discussed
Published in Pharma Law Weekly, July 14th, 2009
"The primary focus is on interventions assessed in systematic reviews and meta-analyses of randomized trials," wrote L.L. Gluud and colleagues, Gentofte University.
The researchers concluded: "The interventions assessed include active and passive immunization for hepatitis A and B and treatments for hepatitis B and C. The results of meta-analyses on conventional interferon-alpha, pegylated interferon alpha, lamivudine, adefovir, and interferon plus ribavirin are summarized."
Gluud and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-07-14)
More Articles from Pharma Law Weekly
- 41st Parameter Inc.
41st Parameter Names J. Peter Selda as Chief Executive Officer - ACS
ACS Acquires Pharm/DUR to Strengthen Pharmacy Audit and Verification Capabilities - Aerospace Industries Association
Sylvester to Lead AIA Procurement & Finance Department - American College of Physicians
IOM CER Committee releases recs to Congress for health-care priorities, funding - American Values
Bauer Commends Supreme Court Ruling in the Ricci Case: Applauds the Use of 'Martin Luther King Test' - Aon Corporation
Aon Names Peter Lieb as General Counsel - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
